Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.
Use this NKTR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NKTR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NKTR SEC filings page. Lician reads the product cache first so this HTML stays unique to Nektar Therapeutics even when a live quote feed is slow.
Latest cached year on this hub. Full NKTR income, balance, and cash tables.